These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18721566)

  • 1. Is aprotinin safe to use in a cohort at increased risk for thrombotic events: results from a randomized, prospective trial in off-pump coronary artery bypass.
    Grant MC; Kon Z; Joshi A; Christenson E; Kallam S; Burris N; Gu J; Poston RS
    Ann Thorac Surg; 2008 Sep; 86(3):815-22; discussion 815-22. PubMed ID: 18721566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial investigating the relationship between aprotinin and hypercoagulability in off-pump coronary surgery.
    Desai PH; Kurian D; Thirumavalavan N; Desai SP; Ziu P; Grant M; White C; Landis RC; Poston RS
    Anesth Analg; 2009 Nov; 109(5):1387-94. PubMed ID: 19843776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of half-dose aprotinin in off-pump coronary artery bypass grafting.
    Wei M; Jian K; Guo Z; Li P; Han J; Cai Z; Tarkka M
    World J Surg; 2006 Jun; 30(6):1108-14. PubMed ID: 16736344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M; Chavanon O; Tessier Y; Meyer C; Casez M; Bach V; Maitrasse B; Girardet P
    J Card Surg; 2006; 21(1):17-21. PubMed ID: 16426342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
    Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
    Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprotinin and perioperative complications in cardiac surgery.
    Kertai MD; Varga KS; Royston D; London MJ; Szabolcs Z; Grebenik CR; Acsady G; Gal J
    J Cardiovasc Surg (Torino); 2007 Dec; 48(6):761-72. PubMed ID: 17947935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin.
    Poston RS; Gu J; White C; Jeudy J; Nie L; Brown J; Gammie J; Pierson RN; Romar L; Griffith BP
    Transfusion; 2008 Mar; 48(1 Suppl):39S-46S. PubMed ID: 18302581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin-associated risks in off-pump coronary artery bypass grafting.
    Bittner HB; Lange M; Lemke J; Rastan A; Mohr FW
    Thorac Cardiovasc Surg; 2009 Dec; 57(8):455-9. PubMed ID: 20013617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of aprotinin for hemostasis during intracranial surgery.
    Palmer JD; Francis JL; Pickard JD; Iannotti F
    J Neurosurg; 2003 Jun; 98(6):1208-16. PubMed ID: 12816266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial).
    Benedetto U; Altman DG; Gerry S; Gray A; Lees B; Angelini GD; Flather M; Taggart DP;
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29502105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial.
    D'Ambra MN; Akins CW; Blackstone EH; Bonney SL; Cohn LH; Cosgrove DM; Levy JH; Lynch KE; Maddi R
    J Thorac Cardiovasc Surg; 1996 Oct; 112(4):1081-9. PubMed ID: 8873736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting.
    Poston R; Gu J; Manchio J; Lee A; Brown J; Gammie J; White C; Griffith BP
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):584-91. PubMed ID: 15784355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
    Ashraf S; Tian Y; Cowan D; Nair U; Chatrath R; Saunders NR; Watterson KG; Martin PG
    Ann Thorac Surg; 1997 Jan; 63(1):68-73. PubMed ID: 8993243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aprotinin reduces bleeding during off-pump coronary artery bypass grafting in a patient on ticlopidine; report of a case].
    Iwahashi H; Tashiro T; Morishige N; Hayashida Y; Ito N; Takeuchi K; Teshima H; Kuwahara G
    Kyobu Geka; 2007 Nov; 60(12):1107-10. PubMed ID: 18018655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin reduces cardiac troponin I release and inhibits apoptosis of polymorphonuclear cells during off-pump coronary artery bypass surgery.
    Bert C; De Buck F; Sergeant P; Van Hemelrijck J; Kasran A; Van Duppen V; Ceuppens J; Meyns B; Delforge M; Wouters P
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):16-22. PubMed ID: 18249325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.